Quince Therapeutics Inc.
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 36 institutions reported holding Quince Therapeutics Inc. in their 13F filings, up 1 from Q4 2024. 7 opened new positions and 5 sold out. The largest holders were Vanguard Group Inc. ($1.7M), Ieq Capital, LLC ($1.1M) and Renaissance Technologies ($665K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Quince Therapeutics Inc.
- CUSIP
- 22053A107
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $1.5M |
| Exits | 5 | $61K |
All 13F filers, Q4 2024 → Q1 2025: 1,226,584 shares bought and 280,610 shares sold, net +945,974 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 36 holders
| Vanguard Group Inc. | 0.00% | Add +1.1% | 1,285,773 | $1.7M |
| Ieq Capital, LLC | 0.01% | New | 806,780 | $1.1M |
| Renaissance Technologies | 0.00% | Reduce -4.4% | 499,907 | $665K |
| Geode Capital Management, LLC | 0.00% | Add +5.3% | 395,710 | $526K |
| BlackRock, Inc. | 0.00% | Reduce -22.9% | 345,448 | $459K |
| HighTower Advisors, LLC | 0.00% | Add +0.6% | 343,570 | $457K |
| Alphabet Inc. | 0.02% | No change | 189,122 | $252K |
| Tang Capital Management LLC | 0.01% | New | 184,383 | $245K |
| Shay Capital LLC | 0.07% | Reduce -33.4% | 184,334 | $245K |
| ADAR1 Capital Management, LLC | 0.04% | No change | 142,958 | $190K |
| State Street Corp. | 0.00% | No change | 124,911 | $166K |
| Mariner, LLC | 0.00% | No change | 122,461 | $163K |
| Bridgeway Capital Management, LLC | 0.00% | Add +15.3% | 106,417 | $142K |
| Scharf Investments, LLC | 0.00% | No change | 91,061 | $121K |
| Northern Trust Corp. | 0.00% | Add +53.4% | 77,492 | $103K |
| Morgan Stanley | 0.00% | Reduce -30.1% | 53,574 | $71K |
| Intellectus Partners, LLC | 0.02% | New | 53,312 | $71K |
| Virtu Financial LLC | 0.00% | Add +48.4% | 43,332 | $58K |
| Two Sigma Investments, LP | 0.00% | Add +35.6% | 41,150 | $55K |
| Citadel Advisors | 0.00% | New | 40,397 | $54K |
| Gsa Capital Partners LLP | 0.00% | New | 36,627 | $49K |
| Anfield Capital Management, LLC | 0.01% | Add +13.4% | 30,227 | $40K |
| HRT Financial LP | 0.00% | Reduce -27.8% | 14,613 | $19K |
| Nixon Peabody Trust Co. | 0.00% | No change | 11,126 | $15K |
| Bank of America Corp. | 0.00% | Reduce -6.1% | 2,844 | $4K |
| UBS Group AG | 0.00% | Reduce -36.6% | 706 | $939 |
| JPMorgan Chase & Co. | 0.00% | Add +0.4% | 547 | $728 |
| JDM Financial Group LLC | 0.00% | No change | 340 | $452 |
| Parallel Advisors, LLC | 0.00% | No change | 295 | $392 |
| Osaic Holdings, Inc. | 0.00% | Reduce -64.6% | 277 | $368 |
| Group One Trading LLC | 0.00% | New | 246 | $327 |
| Hurley Capital, LLC | 0.00% | No change | 121 | $161 |
| Westside Investment Management, Inc. | 0.00% | No change | 75 | $100 |
| SBI Securities Co., Ltd. | 0.00% | No change | 74 | $98 |
| FMR LLC | 0.00% | New | 50 | $67 |
| Barclays PLC | 0.00% | Reduce -77.0% | 23 | $30 |
"% of holder's portfolio" is QUINCE THERAPEUTICS INC's weight in each manager's 13F, not the share of Quince Therapeutics Inc. the manager owns.